AngioDynamics, Inc.
ANGO · NASDAQ
5/31/2025 | 5/31/2024 | 5/31/2023 | 5/31/2022 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | 0.15 | -0.01 | -0.07 | 1.69 |
| FCF Yield | -3.49% | -13.38% | -1.14% | -1.50% |
| EV / EBITDA | 208.37 | -29.72 | 32.27 | 69.23 |
| Quality | ||||
| ROIC | -19.57% | -80.05% | -10.64% | -5.18% |
| Gross Margin | 53.92% | 50.90% | 51.44% | 52.41% |
| Cash Conversion Ratio | 0.30 | 0.15 | -0.00 | 0.27 |
| Growth | ||||
| Revenue 3-Year CAGR | -4.78% | -1.31% | 5.19% | 6.18% |
| Free Cash Flow Growth | 56.99% | -693.78% | 62.81% | -160.78% |
| Safety | ||||
| Net Debt / EBITDA | -32.16 | 11.63 | 1.64 | 0.45 |
| Interest Coverage | 0.00 | 0.00 | -18.94 | -41.38 |
| Efficiency | ||||
| Inventory Turnover | 2.17 | 2.46 | 2.97 | 2.93 |
| Cash Conversion Cycle | 131.59 | 115.99 | 89.93 | 121.84 |